[go: up one dir, main page]

PT1176192E - Vacina de helicobacter felis - Google Patents

Vacina de helicobacter felis

Info

Publication number
PT1176192E
PT1176192E PT01202666T PT01202666T PT1176192E PT 1176192 E PT1176192 E PT 1176192E PT 01202666 T PT01202666 T PT 01202666T PT 01202666 T PT01202666 T PT 01202666T PT 1176192 E PT1176192 E PT 1176192E
Authority
PT
Portugal
Prior art keywords
subunit polypeptides
helicobacter felis
nucleic acid
acid sequences
vaccines
Prior art date
Application number
PT01202666T
Other languages
English (en)
Inventor
Johannes Gerardus Kusters
Giovanni Cattoli
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT1176192E publication Critical patent/PT1176192E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
PT01202666T 2000-07-17 2001-07-11 Vacina de helicobacter felis PT1176192E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202565 2000-07-17

Publications (1)

Publication Number Publication Date
PT1176192E true PT1176192E (pt) 2004-01-30

Family

ID=8171823

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01202666T PT1176192E (pt) 2000-07-17 2001-07-11 Vacina de helicobacter felis

Country Status (10)

Country Link
US (1) US7514547B2 (pt)
EP (1) EP1176192B1 (pt)
JP (1) JP2002355054A (pt)
AT (1) ATE251215T1 (pt)
AU (1) AU782172B2 (pt)
CA (1) CA2351110A1 (pt)
DE (1) DE60100879T2 (pt)
DK (1) DK1176192T3 (pt)
ES (1) ES2208519T3 (pt)
PT (1) PT1176192E (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8029777B2 (en) * 2004-08-13 2011-10-04 Marshall Barry J Helicobacter system and uses thereof
CA2576280A1 (en) 2004-08-13 2006-02-16 Barry J. Marshall Helicobacter pylori-based delivery system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
JPH08509873A (ja) * 1993-05-19 1996-10-22 アンスティテュ・パストゥール ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列
US6258359B1 (en) * 1993-05-19 2001-07-10 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
EP0821698A4 (en) * 1995-04-21 2005-06-29 Csl Ltd HELICOBACTER PROTECTIVE ANTIGENS
JP3007037B2 (ja) * 1995-07-19 2000-02-07 秀実 高橋 ヘリコバクター・ピロリ菌ウレアーゼ蛋白由来の人工抗原及びその人工抗原によって誘発された抗体
GB2307987A (en) * 1995-12-06 1997-06-11 Univ Manchester Epitopes of the urease of Helicobacter pylori as dignostic agents; pharmaceuticals comprising such epitopes or the antibodies thereto
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
US20030158396A1 (en) * 1997-07-29 2003-08-21 Harold Kleanthous Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US5985631A (en) * 1997-09-12 1999-11-16 Oravax-Merieux Co. Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
EP1278768B1 (en) * 2000-04-27 2006-11-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens

Also Published As

Publication number Publication date
ATE251215T1 (de) 2003-10-15
JP2002355054A (ja) 2002-12-10
EP1176192B1 (en) 2003-10-01
DE60100879D1 (de) 2003-11-06
US7514547B2 (en) 2009-04-07
EP1176192A3 (en) 2002-02-06
AU5432101A (en) 2002-01-24
ES2208519T3 (es) 2004-06-16
DE60100879T2 (de) 2004-05-19
CA2351110A1 (en) 2002-01-17
DK1176192T3 (da) 2004-02-02
EP1176192A2 (en) 2002-01-30
AU782172B2 (en) 2005-07-07
US20040005325A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
DK1219711T3 (da) Lawsonia Intracellularis vaccine
EA200700849A1 (ru) Первичная/бустерная противомалярийная вакцина
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
PT1176192E (pt) Vacina de helicobacter felis
ZA200602107B (en) Piroplasmid vaccine
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
TW200801034A (en) Novel sea lice vaccine
DK0995799T3 (da) Coccidiose-vacciner
HUP0200832A2 (hu) Babesia canis oltóanyag
ATE374622T1 (de) Genetische impstoffe mit adjuvans
DE60025522D1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
WO2004024769A3 (en) Ostertagia vaccine
ATE450546T1 (de) Impfstoffe mit ornithobakterium rhinotracheale- untereinheit
TH62170A (th) วัคซีนเชื้อก่อโรค Lawsonia intracellularis
ATE460945T1 (de) Genetische adjuvanz-impfstoffe